- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Condoleezza Rice puts IRs in the spotlight
In 2002, the Society of Interventional Radiology launched a campaign to draw attention to uterine fibroid embolization. Last November, the procedure received national exposure following Secretary-of-State-designate Condoleezza Rice's successful intervention.
In 2002, the Society of Interventional Radiology launched a campaign to draw attention to uterine fibroid embolization. Last November, the procedure received national exposure following Secretary-of-State-designate Condoleezza Rice's successful intervention.
Dr. James Spies, chief of radiology at Georgetown University Hospital and a noted expert on UFE, performed the procedure.
"That such a prominent person would review the choices available to her and prefer embolization helps other women to feel comfortable with considering it and their physicians to consider offering it as an option," Spies said.
The treatment proceeded smoothly with no complications, and Rice returned home after an overnight stay in the hospital. Studies have consistently shown UFE to be effective when compared with both myomectomy and hysterectomy, and it has a short recovery time.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
